Tirzepatide is a GIP-analogue that activates both the GLP-1 and GIP receptors, leading to improved blood-sugar control. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood-sugar control.
After a person has eaten, these hormones are secreted by cells of the intestines, and in turn cause the secretion of insulin.
It is a Mounjaro and Zepbound alternative. An antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. It is administered through subcutaneous injection (under the skin).
Tirzepatide is indicated to improve blood-sugar control in adults with type 2 diabetes, as an addition to diet and exercise.
It is also indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management.
